poliomyelitis oral, monovalent, live attenuated

North America

Canada (0)
No result.
United States (0)
No result.

Europe

Austria (0)
No result.
Belgium (4)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
POLIO SABIN MONO ONE oral susp
10x
20x
-
-

oral
J07BF01
POLIO SABIN MONO THREE (ORAL) oral susp
10x
20x
-
-

oral
J07BF01
POLIO SABIN MONO TWO oral susp
10x
20x
-
-

oral
J07BF01
POLIO SABIN ONE AND THREE (ORAL) oral susp
10x
20x
-
-

oral
J07BF01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
POLIO SABIN MONO ONE oral susp
10x
20x
BE274391
BE274391
-
-
POLIO SABIN MONO THREE (ORAL) oral susp
10x
20x
BE289152
BE289152
-
-
POLIO SABIN MONO TWO oral susp
10x
20x
BE389882
BE389882
-
-
POLIO SABIN ONE AND THREE (ORAL) oral susp
10x
20x
BE349334
BE349334
-
-
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
POLIO SABIN MONO ONE oral susp
10x
20x
POLIO SABIN MONO THREE (ORAL) oral susp
10x
20x
POLIO SABIN MONO TWO oral susp
10x
20x
POLIO SABIN ONE AND THREE (ORAL) oral susp
10x
20x
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Bosnia and Herzegovina (0)
No result.
Croatia (0)
No result.
Czechia (0)
No result.
Denmark (0)
No result.
Finland (0)
No result.
Hungary (0)
No result.
Iceland (0)
No result.
Ireland (0)
No result.
Lithuania (0)
No result.
Malta (0)
No result.
Netherlands (0)
No result.
Norway (0)
No result.
Poland (0)
No result.
Romania (0)
No result.
Slovenia (0)
No result.
Spain (0)
No result.
Sweden (0)
No result.
Switzerland (0)
No result.